1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: The following table shows the “Rule 10b5-1 trading arrangements” and “non-Rule 10b5-1 trading arrangements” (as each term is defined in Item 408(a) of Regulation S-K) adopted by our directors and executive officers during the quarter ended September 30, 2023.
−Removed: No trading arrangements were terminated by our directors and executive officers during the quarter ended September 30, 2023.
+Added: The following table shows the “Rule 10b5-1 trading arrangements” and “non-Rule 10b5-1 trading arrangements” (as each term is defined in Item 408(a) of Regulation S-K) adopted by our directors and executive officers during the quarter ended March 31, 2024.
+Added: No trading arrangements were terminated by our directors and executive officers during the quarter ended March 31, 2024.
Trading Arrangement
2 unchanged sentences
Shares to be Sold Expiration
−Removed: Reinhart, III
−Removed: Chief Financial Officer
−Removed: 7/5/2023 x To Be Determined (2)
+Added: Principal Accounting Officer
+Added: Adopt 3/5/2024 x To Be Determined (1)
Kristen Williams
Chief Administrative Officer and Secretary
−Removed: 7/27/2023 x To Be Determined (2)
−Removed: Chief Medical Officer and Orthopedic Franchise
Adopt 3/8/2024 x To Be Determined (1)
+Added: Jonathan Slonin
+Added: Chief Medical Officer
+Added: Adopt 3/8/2024 x To Be Determined (1)
+Added: Paul Hastings
+Added: Adopt 3/12/2024 x 1,775 12/31/2024
+Added: Daryl Gaugler
+Added: Chief Operating Officer
+Added: Adopt 3/12/2024 x 2,500 3/7/2025
* Intended to satisfy the affirmative defense of Rule 10b5-1(c).
** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
−Removed: (1) Represents an election made upon acceptance of a grant of restricted stock units made in June 2023 to sell shares to cover tax withholding obligations upon vesting.
(1) The aggregate number of shares to be sold pursuant to each trading arrangement listed above is dependent on the amount of tax withholding required upon the vesting of restricted stock units, and, therefore, is indeterminable at this time.
−Removed: Winston’s trading arrangement includes 11,472 long shares to be sold upon the Company’s common stock reaching a specified limit price.
Pacira BioSciences, Inc.
2 unchanged sentences
Exhibit Number Description
−Removed: Transition and Retirement Agreement, dated September 20, 2023, between the Company and David Stack.(1) †
−Removed: Certification of Chief Executive Officer and Chairman pursuant to Rule 13a-14(a) and 15d-14(a), as amended.*
+Added: Executive Employment Agreement, dated May 4, 2020, between the Registrant and Jonathan Slonin.(1) ***
+Added: Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a), as amended.*
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a), as amended.*
−Removed: Certification of Chief Executive Officer and Chairman and Chief Financial Officer pursuant to 18 U.S.C.
+Added: Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101 The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc.
−Removed: for the quarter ended September 30, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: for the quarter ended March 31, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets;
8 unchanged sentences
*** Denotes management contract or compensatory plan or arrangement.
−Removed: (1) Incorporated by reference to the Company’s Current Report on Form 8-K, filed on September 26, 2023.
+Added: (1) Incorporated by reference to the Company’s Quarterly Report on Form 10-Q, filed on May 4, 2022.
Pacira BioSciences, Inc.
2 unchanged sentences
PACIRA BIOSCIENCES, INC.
−Removed: November 2, 2023 By:
−Removed: /s/ DAVID STACK
−Removed: Chief Executive Officer and Chairman
+Added: May 7, 2024 By:
+Added: Chief Executive Officer and Director
(Principal Executive Officer)
−Removed: November 2, 2023 By:
+Added: May 7, 2024 By:
/s/ CHARLES A.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.